Literature DB >> 25663612

Response to the letter by Brotherton regarding "insoluble fiber and intestinal microbiota metabolism".

Jason R Goldsmith1, R Balfour Sartor.   

Abstract

Mesh：

Year:  2015        PMID： 25663612     DOI： 10.1007/s00535-015-1044-5

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  6 in total

1.  Fermentation of dietary fibre in the intestinal tract: comparison between man and rat.

Authors:  M Nyman; N G Asp; J Cummings; H Wiggins
Journal:  Br J Nutr       Date:  1986-05       Impact factor: 3.718

Review 2.  The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications.

Authors:  Jason R Goldsmith; R Balfour Sartor
Journal:  J Gastroenterol       Date:  2014-03-21       Impact factor: 7.527

3.  Wheat bran affects the site of fermentation of resistant starch and luminal indexes related to colon cancer risk: a study in pigs.

Authors:  M J Govers; N J Gannon; F R Dunshea; P R Gibson; J G Muir
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

4.  The cellulose-degrading microbial community of the human gut varies according to the presence or absence of methanogens.

Authors:  Christophe Chassard; Eve Delmas; Céline Robert; Annick Bernalier-Donadille
Journal:  FEMS Microbiol Ecol       Date:  2010-07-19       Impact factor: 4.194

5.  A high-fiber diet may improve bowel function and health-related quality of life in patients with Crohn disease.

Authors:  Carol S Brotherton; Ann Gill Taylor; Cheryl Bourguignon; Joel G Anderson
Journal:  Gastroenterol Nurs       Date:  2014 May-Jun       Impact factor: 0.978

6.  Membership and behavior of ultra-low-diversity pathogen communities present in the gut of humans during prolonged critical illness.

Authors:  Alexander Zaborin; Daniel Smith; Kevin Garfield; John Quensen; Baddr Shakhsheer; Matthew Kade; Matthew Tirrell; James Tiedje; Jack A Gilbert; Olga Zaborina; John C Alverdy
Journal:  mBio       Date:  2014-09-23       Impact factor: 7.867
  6 in total
  1 in total

1.  Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease.

Authors:  S Kusaka; A Nishida; K Takahashi; S Bamba; H Yasui; M Kawahara; O Inatomi; M Sugimoto; A Andoh
Journal:  Clin Exp Immunol       Date:  2017-09-28       Impact factor: 4.330
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.